Pulse Biosciences Inc (NASDAQ:PLSE) — Market Cap & Net Worth
Market Cap & Net Worth: Pulse Biosciences Inc (PLSE)
Pulse Biosciences Inc (NASDAQ:PLSE) has a market capitalization of $1.30 Billion ($1.30 Billion) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7947 globally and #2284 in its home market, demonstrating a -1.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pulse Biosciences Inc's stock price $25.45 by its total outstanding shares 68225067 (68.23 Million). Review how much debt does Pulse Biosciences Inc carry to assess the company's total debt and financial obligations.
Pulse Biosciences Inc Market Cap History: 2016 to 2026
Pulse Biosciences Inc's market capitalization history from 2016 to 2026. Data shows growth from $443.46 Million to $1.74 Billion (19.64% CAGR).
Index Memberships
Pulse Biosciences Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.05% | #221 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #848 of 3165 |
Weight: Pulse Biosciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Pulse Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pulse Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2676.37x
Pulse Biosciences Inc's market cap is 2676.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $443.46 Million | $68.00K | -$9.52 Million | 6521.51x | N/A |
| 2017 | $1.61 Billion | $247.00K | -$25.57 Million | 6518.67x | N/A |
| 2020 | $1.63 Billion | $114.00K | -$49.74 Million | 14279.39x | N/A |
| 2021 | $1.01 Billion | $1.42 Million | -$63.16 Million | 712.56x | N/A |
| 2022 | $188.98 Million | $700.00K | -$58.95 Million | 269.98x | N/A |
| 2023 | $835.07 Million | $-9.00K | -$42.21 Million | -92786.09x | N/A |
| 2025 | $936.73 Million | $350.00K | -$72.78 Million | 2676.37x | N/A |
Competitor Companies of PLSE by Market Capitalization
Companies near Pulse Biosciences Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Pulse Biosciences Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #164 globally with a market cap of $142.44 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #267 globally with a market cap of $94.60 Billion USD ( €80.92 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #340 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #542 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | Intuitive Surgical Inc | NASDAQ:ISRG | $142.44 Billion | $402.18 |
| #267 | EssilorLuxottica S. A. | PA:EL | $94.60 Billion | €174.75 |
| #340 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.50 |
| #542 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Pulse Biosciences Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Pulse Biosciences Inc's market cap moved from $443.46 Million to $ 1.74 Billion, with a yearly change of 19.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.74 Billion | +85.36% |
| 2025 | $936.73 Million | -21.14% |
| 2024 | $1.19 Billion | +42.24% |
| 2023 | $835.07 Million | +341.88% |
| 2022 | $188.98 Million | -81.30% |
| 2021 | $1.01 Billion | -37.93% |
| 2020 | $1.63 Billion | +77.93% |
| 2019 | $914.90 Million | +17.02% |
| 2018 | $781.86 Million | -51.44% |
| 2017 | $1.61 Billion | +263.08% |
| 2016 | $443.46 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Pulse Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.30 Billion USD |
| MoneyControl | $1.30 Billion USD |
| MarketWatch | $1.30 Billion USD |
| marketcap.company | $1.30 Billion USD |
| Reuters | $1.30 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac… Read more